Semaglutide vs AOD-9604
A comprehensive, data-driven comparison of Semaglutide (Ozempic) and AOD-9604 (Advanced Obesity Drug). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | Semaglutide Ozempic, Wegovy | AOD-9604 Advanced Obesity Drug, Tyr-hGH Fragment 176-191 |
|---|---|---|
| FDA Status | FDA Approved | Phase 2 (failed; reclassification pending) |
| Category | Weight Loss | Weight Loss |
| Primary Use | Type 2 diabetes, chronic weight management, and MASH | Fat loss and metabolism enhancement |
| Weight Loss % | 15% | N/A |
| Monthly Cost | $1,000 - $1,400/mo | $30 - $60/mo |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Typical Dose | 2.4mg weekly (Wegovy dose) | 300mcg daily |
| Frequency | Weekly | Daily |
| Mechanism | GLP-1 receptor agonist that mimics incretin hormone to increase insulin secretion, slow gastric emptying, and reduce appetite | Modified fragment of human growth hormone (amino acids 176-191) that stimulates lipolysis without affecting blood sugar or IGF-1 |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | High | Low |
| Clinical Trial Phase | Approved | Phase 2 |
Key Differences
- 1Semaglutide is FDA-approved, while AOD-9604 is currently phase 2 (failed; reclassification pending).
- 2Semaglutide has clinical weight loss data (15%), while AOD-9604 is not primarily indicated for weight loss.
- 3AOD-9604 is generally more affordable ($30 - $60/mo) compared to Semaglutide ($1,000 - $1,400/mo).
- 4Semaglutide is dosed weekly, while AOD-9604 is daily.
- 5Semaglutide has high-quality evidence, while AOD-9604 has low-quality evidence.
Which Is Better For...
Semaglutide
Those seeking an FDA-approved treatment with established safety data
AOD-9604
More budget-friendly option with lower monthly costs
Semaglutide
More convenient dosing schedule (weekly)
AOD-9604
Fewer commonly reported side effects
Semaglutide
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| Semaglutide | $1,000 - $1,400/mo | FDA Approved | Novo Nordisk |
| AOD-9604 | $30 - $60/mo | Phase 2 (failed; reclassification pending) | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
Semaglutide works via GLP-1 receptor agonist that mimics incretin hormone to increase insulin secretion, slow. AOD-9604 works via Modified fragment of human growth hormone (amino acids 176-191) that stimulates lipolysis. They differ in FDA approval status, efficacy data, and cost.
Semaglutide has demonstrated 15% average weight loss in clinical trials. AOD-9604 is not primarily used for weight loss.
Semaglutide typically costs $1,000 - $1,400/mo, while AOD-9604 costs $30 - $60/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
Semaglutide is FDA-approved. AOD-9604 is not FDA-approved (Phase 2 (failed; reclassification pending)). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of Semaglutide include Nausea, Diarrhea, Vomiting. Common side effects of AOD-9604 include Injection site reactions, Headache, Chest tightness (rare). Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
Semaglutide is an FDA-approved GLP-1 receptor agonist marketed as Ozempic for type 2 diabetes and Wegovy for chronic weight management. In August 2025, it received accelerated approval for MASH (metab...
View Full Semaglutide GuideAOD-9604 is a modified peptide fragment of the C-terminus of human growth hormone (amino acids 176-191). It was designed to retain the fat-burning properties of HGH while avoiding effects on blood sug...
View Full AOD-9604 GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between Semaglutide and AOD-9604 should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.